Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells - Nature Biotechnology

  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells

. pMSGV1.MuSK-CAAR was generated by replacing the 1D3-28Z.1-3 mut insert with the MuSK-CAAR sequence. Then 30 μg of each plasmid was transfected into the Plat-E packaging cell line to produce retroviruses.MG3, a 57-year-old female, chronic active disease. MG5, a 34-year-old female, chronic active disease. Venipuncture was performed under a protocol approved by the University of Pennsylvania Institutional Review Board.

Bulk primary human T cells ) were cultured in human T cell culture media supplemented with 100 IU mlrhIL-2 plus 5% human AB serum or Roswell Park Memorial Institute media supplemented with 10% FBS, 10 mM HEPES, 1% penicillin/streptomycin and 1% GlutaMax). T cells were activated/selected with anti-CD3/CD28-coated paramagnetic beads at a 3/1 bead/cell ratio.

Donor-matched MuSK-CAART and NTD-T were incubated with BCR-negative Nalm-6 control cells or mixture of Nalm-6 MuSK target cells at E:T ratio of either 1:1 or 10:1 for 24 h. Purified IgG from two patients with MuSK MG was added at a final concentration of 10 mg mlIgG before coincubation. MuSK-CAART cytotoxicity was evaluated at 8 and 24 h using luciferase-based killing assay.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Awesome!

PennMedicine CabalettaBio UCDavisHealth NeurologyYale Targeting autoimmune B-cells with chimeric autoantibody receptors (CAARs): behindthepaper with co-authors Silvio Manfredo-Vieira and Aimee S. Payne

PennMedicine CabalettaBio UCDavisHealth NeurologyYale CAR T-like treatment for rare form of autoimmune disease NBTintheNews via PennMedicine

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 231. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The next giant step for microbes - Nature BiotechnologyThe next giant step for microbes A microbiome therapy is approved by the FDA for treatment of Clostridioides difficile. What’s next? ferring finch_tx VedantaBio ResearchViome FederationBio BankBiome Tailored probiotics for the individual ferring finch_tx VedantaBio ResearchViome FederationBio BankBiome Next step is obvious;
Source: NatureBiotech - 🏆 231. / 63 Read more »

ACG Publishes New Guidelines for Celiac DiseaseThe AmCollegeGastro issued updated guidelines for celiacdisease diagnosis, management, and screening that incorporates research conducted since the last update in 2013. GastroTwitter
Source: Medscape - 🏆 386. / 55 Read more »